Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
DNAJB4	11080	broad.mit.edu	37	1	78478954	78478954	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr1:78478954G>C	ENST00000370763.5	+	2	688	c.431G>C	c.(430-432)aGa>aCa	p.R144T	DNAJB4_ENST00000487931.1_3'UTR|GIPC2_ENST00000476882.1_Intron	NM_007034.3	NP_008965.2	Q9UDY4	DNJB4_HUMAN	DnaJ (Hsp40) homolog, subfamily B, member 4	144		NA		NA	protein folding|response to heat|response to unfolded protein	cytoplasm|plasma membrane	heat shock protein binding|unfolded protein binding		NA	endometrium(1)|kidney(1)|large_intestine(2)|lung(4)|ovary(1)|upper_aerodigestive_tract(1)	10						GGATATCCAAGAGACAGGAAT	0.413		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													139	137	138	NA		NA	NA	1		NA											NA				78478954		2203	4300	6503	SO:0001583	missense			ENSG00000162616	HGNC:14886		Approved	uc001dij.3	NA	B2R824|Q13431	ENST00000370763.5	37	CCDS684.1	.	.	.	.	.	.	.	.	.	.	G	16.89	3.246916	0.59103	.	.	ENSG00000162616	ENST00000426517;ENST00000370763	T;T	0.64803	-0.12;0.29	5.26	5.26	0.73747	.	0.000000	0.85682	D	0.000000	T	0.38295	0.1035	L	0.38953	1.18	0.80722	D	1	B	0.17465	0.022	B	0.18561	0.022	T	0.35375	-0.9791	10	0.13853	T	0.58	.	18.928	0.92553	0.0:0.0:1.0:0.0	.	144	Q9UDY4	DNJB4_HUMAN	T	144	ENSP00000399494:R144T;ENSP00000359799:R144T	ENSP00000359799:R144T	R	+	2	0	DNAJB4	78251542	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	9.864000	0.99589	2.439000	0.82584	0.644000	0.83932	AGA	DNAJB4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000098248.3	3.257305	KEEP		+	24.691383	0.082645	10	111	---	---	---	---	1	0.9961704	12	104	0	141	10	115	0	141	2	0	0	0	0	0	0	10	115	0	141	2	TP
TTC27	55622	broad.mit.edu	37	2	33036261	33036261	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr2:33036261G>C	ENST00000317907.4	+	17	2400	c.2169G>C	c.(2167-2169)caG>caC	p.Q723H		NM_001193509.1|NM_017735.4	NP_001180438.1|NP_060205.3	Q6P3X3	TTC27_HUMAN	tetratricopeptide repeat domain 27	723		NA		NA			protein binding		NA	breast(1)|central_nervous_system(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(3)|kidney(1)|large_intestine(9)|lung(14)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	38						GAAATGGGCAGAGTGAAAAGC	0.428		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													102	104	103	NA		NA	NA	2		NA											NA				33036261		2203	4300	6503	SO:0001583	missense			ENSG00000018699	HGNC:25986	NM_017735	Approved	uc002rom.3	NA	A6NKJ0|Q96SS5|Q9BVF1|Q9NWR4|Q9NXG4	ENST00000317907.4	37	CCDS33176.1	.	.	.	.	.	.	.	.	.	.	G	8.030	0.761644	0.15914	.	.	ENSG00000018699	ENST00000317907	T	0.60040	0.22	5.22	3.45	0.39498	.	0.330721	0.35772	N	0.002986	T	0.37046	0.0989	L	0.27053	0.805	0.31363	N	0.681115	B	0.02656	0.0	B	0.04013	0.001	T	0.29366	-1.0014	10	0.15066	T	0.55	-13.7778	6.2682	0.20939	0.2164:0.1334:0.6502:0.0	.	723	Q6P3X3	TTC27_HUMAN	H	723	ENSP00000313953:Q723H	ENSP00000313953:Q723H	Q	+	3	2	TTC27	32889765	1.000000	0.71417	1.000000	0.80357	0.364000	0.29643	0.627000	0.24506	0.792000	0.33850	0.650000	0.86243	CAG	TTC27-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000325395.1	9.189065	KEEP		+	11.936385	0.16	4	21	---	---	---	---	1	0.9514146	10	26	0	39	4	23	0	39	2	0	0	0	0	0	0	4	23	0	39	2	TP
KIF5C	3800	broad.mit.edu	37	2	149857246	149857246	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr2:149857246G>C	ENST00000435030.1	+	21	2691	c.2323G>C	c.(2323-2325)Gat>Cat	p.D775H	KIF5C_ENST00000397413.1_Missense_Mutation_p.D543H|KIF5C_ENST00000464066.1_3'UTR|KIF5C_ENST00000414838.2_Missense_Mutation_p.D680H			O60282	KIF5C_HUMAN	kinesin family member 5C	775		NA		NA	microtubule-based movement|organelle organization	cytoplasm|kinesin complex|microtubule	ATP binding|microtubule motor activity		NA	endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(13)|lung(12)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)	36				BRCA - Breast invasive adenocarcinoma(221;0.108)		ATTGCTCAACGATAAAAGGGA	0.423		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													189	173	178	NA		NA	NA	2		NA											NA				149857246		1855	4105	5960	SO:0001583	missense			ENSG00000168280	HGNC:6325	NM_004522	Approved	uc010zbu.2	NA	O95079|Q2YDC5	ENST00000435030.1	37		.	.	.	.	.	.	.	.	.	.	G	18.52	3.640792	0.67244	.	.	ENSG00000168280	ENST00000435030;ENST00000414838;ENST00000334436;ENST00000397413	T;T;T	0.80033	-1.33;-1.33;-1.33	5.01	5.01	0.66863	.	0.196392	0.47852	D	0.000207	T	0.74473	0.3721	.	.	.	0.58432	D	0.999994	B;B	0.28971	0.037;0.229	B;B	0.30646	0.048;0.118	T	0.69888	-0.5023	8	.	.	.	.	18.5179	0.90942	0.0:0.0:1.0:0.0	.	775;83	O60282;Q59GB8	KIF5C_HUMAN;.	H	775;680;678;543	ENSP00000393379:D775H;ENSP00000410115:D680H;ENSP00000380560:D543H	.	D	+	1	0	KIF5C	149565492	1.000000	0.71417	1.000000	0.80357	0.955000	0.61496	9.657000	0.98554	2.601000	0.87937	0.655000	0.94253	GAT	KIF5C-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000332562.3	101.076753	KEEP		+	103.68728	0.326531	32	66	---	---	---	---	1	1	26	100	0	140	36	80	0	140	2	0	0	0	0	0	0	36	80	0	140	2	TP
COQ10B	80219	broad.mit.edu	37	2	198318368	198318368	+	Silent	SNP	G	G	A			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr2:198318368G>A	ENST00000263960.2	+	1	222	c.84G>A	c.(82-84)caG>caA	p.Q28Q	COQ10B_ENST00000409010.1_5'Flank|COQ10B_ENST00000545340.1_5'Flank|COQ10B_ENST00000409398.1_Silent_p.Q28Q	NM_025147.3	NP_079423.1	Q9H8M1	CQ10B_HUMAN	coenzyme Q10 homolog B (S. cerevisiae)	28		NA		NA		mitochondrial inner membrane			NA	endometrium(1)|large_intestine(2)|lung(3)	6			Epithelial(96;0.231)|OV - Ovarian serous cystadenocarcinoma(117;0.246)			CCGGGGCGCAGGCGCCCGTGC	0.627		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													33	43	40	NA		NA	NA	2		NA											NA				198318368		2202	4298	6500	SO:0001819	synonymous_variant			ENSG00000115520	HGNC:25819	NM_025147	Approved	uc002uuh.1	NA		ENST00000263960.2	37	CCDS2319.1																																																																																			COQ10B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256105.2	72.428866	KEEP		+	75.567673	0.298851	26	61	---	---	---	---	1	0.9999828	12	37	0	55	30	74	0	55	2	0	0	0	0	0	0	30	74	0	55	2	TP
IDH1	3417	broad.mit.edu	37	2	209113112	209113112	+	Missense_Mutation	SNP	C	C	T	rs121913500		GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr2:209113112C>T	ENST00000415913.1	-	4	776	c.395G>A	c.(394-396)cGt>cAt	p.R132H	IDH1_ENST00000446179.1_Missense_Mutation_p.R132H|IDH1_ENST00000345146.2_Missense_Mutation_p.R132H			O75874	IDHC_HUMAN	isocitrate dehydrogenase 1 (NADP+), soluble	132		NA	R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).	NA	2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle	cytosol|peroxisomal matrix	isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity	p.R132H(2774)|p.R132L(59)|p.R132V(1)|p.G131_R132>VL(1)	NA	NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1)	4887				Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136)		ATAAGCATGACGACCTATGAT	0.393		NA	Mis	NA	gliobastoma		NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(158;264 1958 3300 35450 36047)		Dom	yes		2	2q33.3	3417	"""isocitrate dehydrogenase 1 (NADP+), soluble"""	NA	O	2835	Substitution - Missense(2834)|Complex - compound substitution(1)	central_nervous_system(2579)|haematopoietic_and_lymphoid_tissue(205)|bone(43)|prostate(4)|biliary_tract(2)|urinary_tract(1)|skin(1)											79	73	75	NA		NA	NA	2		NA											NA				209113112		2203	4300	6503	SO:0001583	missense			ENSG00000138413	HGNC:5382		Approved	uc002vcu.3	NA	Q7Z3V0|Q93090|Q9NTJ9|Q9UKW8	ENST00000415913.1	37	CCDS2381.1	.	.	.	.	.	.	.	.	.	.	C	25.6	4.657324	0.88154	.	.	ENSG00000138413	ENST00000345146;ENST00000446179;ENST00000415913;ENST00000415282	D;D;D;D	0.86956	-2.19;-2.19;-2.19;-2.19	5.57	4.69	0.59074	Isopropylmalate dehydrogenase-like domain (2);	0.000000	0.85682	D	0.000000	D	0.93145	0.7817	H	0.99379	4.54	0.80722	D	1	B	0.25486	0.127	B	0.25405	0.06	D	0.92324	0.5868	10	0.87932	D	0	-20.0399	14.3783	0.66895	0.0:0.9288:0.0:0.0712	.	132	O75874	IDHC_HUMAN	H	132	ENSP00000260985:R132H;ENSP00000410513:R132H;ENSP00000390265:R132H;ENSP00000391075:R132H	ENSP00000260985:R132H	R	-	2	0	IDH1	208821357	1.000000	0.71417	0.997000	0.53966	0.992000	0.81027	6.088000	0.71371	1.356000	0.45884	0.555000	0.69702	CGT	IDH1-006	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336672.1	66.458995	KEEP		-	66.567343	0.44898	22	27	---	---	---	---	1	1	77	109	0	88	26	29	0	88	2	0	0.8513844	0	6	0	26	26	29	0	88	2	TP
SMARCC1	6599	broad.mit.edu	37	3	47755965	47755965	+	Silent	SNP	G	G	A			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr3:47755965G>A	ENST00000254480.5	-	8	851	c.732C>T	c.(730-732)gtC>gtT	p.V244V	SMARCC1_ENST00000425518.1_5'UTR	NM_003074.3	NP_003065.3	Q92922	SMRC1_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1	244		NA		NA	chromatin remodeling|nervous system development|transcription, DNA-dependent	nBAF complex|npBAF complex|nucleoplasm|SWI/SNF complex|WINAC complex	DNA binding|protein N-terminus binding|transcription coactivator activity		NA	breast(1)|endometrium(5)|kidney(2)|large_intestine(3)|lung(15)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(2)	33				BRCA - Breast invasive adenocarcinoma(193;7.47e-05)|KIRC - Kidney renal clear cell carcinoma(197;0.00862)|Kidney(197;0.01)		CATTACTATGGACCCAAGTAT	0.274		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													76	81	79	NA		NA	NA	3		NA											NA				47755965		2202	4299	6501	SO:0001819	synonymous_variant			ENSG00000173473	HGNC:11104		Approved	uc003crq.2	NA	Q17RS0|Q6P172|Q8IWH2	ENST00000254480.5	37	CCDS2758.1																																																																																			SMARCC1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257491.1	7.97837	KEEP		-	16.656121	0.116667	7	53	---	---	---	---	1	0.9915532	6	64	0	121	9	70	0	121	2	0	0	0	0	0	0	9	70	0	121	2	TP
DZIP1L	199221	broad.mit.edu	37	3	137799416	137799416	+	Silent	SNP	T	T	C			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr3:137799416T>C	ENST00000327532.2	-	10	1643	c.1281A>G	c.(1279-1281)ccA>ccG	p.P427P	DZIP1L_ENST00000469243.1_Silent_p.P427P|DZIP1L_ENST00000488595.1_5'UTR	NM_173543.2	NP_775814.2	Q8IYY4	DZI1L_HUMAN	DAZ interacting zinc finger protein 1-like	427		NA		NA		intracellular	zinc ion binding		NA	breast(2)|cervix(2)|endometrium(3)|kidney(2)|large_intestine(6)|lung(15)|ovary(1)|pancreas(2)|prostate(1)|skin(1)	35						CACCTTCCTCTGGAGAGTCCT	0.522		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0								C	,	0,4406		0,0,2203	129	113	119	NA	1281,1281	-8.9	0.1	3		119	4,8596	819.1+/-406.8	0,4,4296	no	coding-synonymous,coding-synonymous	DZIP1L	NM_001170538.1,NM_173543.2	,	0,4,6499	CC,CT,TT	NA	0.0465,0.0,0.0308	,	427/540,427/768	137799416	4,13002	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000158163	HGNC:26551	NM_173543	Approved	uc003erq.3	NA	C9JUG5|Q96M38	ENST00000327532.2	37	CCDS3096.1																																																																																			DZIP1L-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000357548.1	106.685938	KEEP		-	106.733967	0.471429	33	37	---	---	---	---	1	0.9376586	4	3	0	71	44	42	0	71	2	0	0	0	0	0	0	44	42	0	71	2	TP
ZBTB38	253461	broad.mit.edu	37	3	141162963	141162963	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr3:141162963A>G	ENST00000514251.1	+	4	2012	c.1733A>G	c.(1732-1734)tAt>tGt	p.Y578C	ZBTB38_ENST00000321464.5_Missense_Mutation_p.Y579C|ZBTB38_ENST00000441582.2_Missense_Mutation_p.Y578C			Q8NAP3	ZBT38_HUMAN	zinc finger and BTB domain containing 38	578		NA		NA	positive regulation of transcription from RNA polymerase II promoter	nucleus	DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding		NA	breast(3)|cervix(4)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(3)|lung(14)|ovary(3)|prostate(2)|skin(3)|urinary_tract(1)	41						AGAGCCCCTTATAAGAGCTAC	0.408		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													63	61	61	NA		NA	NA	3		NA											NA				141162963		1838	4097	5935	SO:0001583	missense			ENSG00000177311	HGNC:26636		Approved	uc003etw.3	NA	D3DNF6	ENST00000514251.1	37	CCDS43157.1	.	.	.	.	.	.	.	.	.	.	a	15.73	2.920226	0.52653	.	.	ENSG00000177311	ENST00000509883;ENST00000514251;ENST00000441582;ENST00000321464	T;T;T;T	0.12039	3.35;2.72;2.72;2.72	5.69	3.26	0.37387	.	0.233180	0.36555	N	0.002521	T	0.28300	0.0699	M	0.66939	2.045	0.34499	D	0.705847	D;D	0.76494	0.999;0.999	D;D	0.64144	0.922;0.922	T	0.31724	-0.9933	9	.	.	.	-12.0748	8.0794	0.30735	0.724:0.1415:0.0:0.1345	.	579;578	B4DYR8;Q8NAP3	.;ZBT38_HUMAN	C	578;578;578;579	ENSP00000424254:Y578C;ENSP00000426387:Y578C;ENSP00000406955:Y578C;ENSP00000372635:Y579C	.	Y	+	2	0	ZBTB38	142645653	1.000000	0.71417	0.863000	0.33907	0.930000	0.56654	6.800000	0.75165	0.406000	0.25560	-0.264000	0.10439	TAT	ZBTB38-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000359329.2	15.729258	KEEP		+	27.908576	0.117647	10	75	---	---	---	---	1	0.9547863	2	46	0	77	10	84	0	77	2	0	0	0	0	0	0	10	84	0	77	2	TP
OGDH	4967	broad.mit.edu	37	7	44747273	44747273	+	Silent	SNP	A	A	G			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr7:44747273A>G	ENST00000222673.5	+	22	2931	c.2889A>G	c.(2887-2889)caA>caG	p.Q963Q	OGDH_ENST00000444676.1_Silent_p.Q978Q|OGDH_ENST00000449767.1_Silent_p.Q959Q|OGDH_ENST00000447398.1_Silent_p.Q974Q|OGDH_ENST00000439616.2_Silent_p.Q813Q|OGDH_ENST00000543843.1_Silent_p.Q914Q	NM_002541.3	NP_002532.2	Q02218	ODO1_HUMAN	oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)	963		NA		NA	glycolysis|lysine catabolic process|tricarboxylic acid cycle	mitochondrial matrix|mitochondrial membrane	oxoglutarate dehydrogenase (succinyl-transferring) activity|thiamine pyrophosphate binding		NA	breast(2)|endometrium(5)|kidney(2)|large_intestine(6)|lung(13)|ovary(1)|prostate(1)|upper_aerodigestive_tract(2)|urinary_tract(4)	36					NADH(DB00157)	ACAAGAACCAAGGCTACTATG	0.592		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													122	100	108	NA		NA	NA	7		NA											NA				44747273		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000105953	HGNC:8124		Approved	uc003tln.3	NA	D3DVL0|Q9UDX0	ENST00000222673.5	37	CCDS34627.1																																																																																			OGDH-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000339391.1	-5.34291	KEEP		+	18.062979	0.060345	7	109	---	---	---	---	1	0.999985	8	400	0	93	8	118	0	93	2	0	0	0	0	0	0	8	118	0	93	2	TP
ERLIN2	11160	broad.mit.edu	37	8	37611537	37611537	+	Silent	SNP	T	T	C			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr8:37611537T>C	ENST00000276461.5	+	12	991	c.924T>C	c.(922-924)tcT>tcC	p.S308S	ERLIN2_ENST00000519638.1_Silent_p.S308S	NM_007175.6	NP_009106.1	O94905	ERLN2_HUMAN	ER lipid raft associated 2	308	Interaction with ERLIN1.	NA		NA	ER-associated protein catabolic process	endoplasmic reticulum membrane|integral to membrane|plasma membrane	protein binding		NA	NS(1)|large_intestine(1)|lung(5)	7		Lung NSC(58;0.174)	BRCA - Breast invasive adenocarcinoma(5;6.14e-24)|LUSC - Lung squamous cell carcinoma(8;3.5e-10)			TCATGGACTCTGCGGGCAGTG	0.463		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													110	97	101	NA		NA	NA	8		NA											NA				37611537		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000147475	HGNC:1356	NM_007175	Approved	uc003xke.4	NA	A0JLQ1|A8K5S9|B4DM38|D3DSW0|Q6NW21|Q86VS6|Q86W49	ENST00000276461.5	37	CCDS6095.1																																																																																			ERLIN2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000376712.2	4.034581	KEEP		+	18.368768	0.093023	8	78	---	---	---	---	1	0.9982169	9	90	0	67	10	85	0	67	2	0	0	0	0	0	0	10	85	0	67	2	TP
DLG5	9231	broad.mit.edu	37	10	79581222	79581222	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr10:79581222G>A	ENST00000372391.2	-	15	3025	c.3020C>T	c.(3019-3021)gCg>gTg	p.A1007V	DLG5_ENST00000459739.1_5'UTR|DLG5_ENST00000372388.2_Intron	NM_004747.3	NP_004738.3	Q8TDM6	DLG5_HUMAN	discs, large homolog 5 (Drosophila)	1007	Pro-rich.	NA		NA	cell-cell adhesion|intracellular signal transduction|negative regulation of cell proliferation|regulation of apoptosis	cell junction|cytoplasm	beta-catenin binding|cytoskeletal protein binding|receptor signaling complex scaffold activity		NA	breast(9)|central_nervous_system(3)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(8)|lung(17)|ovary(5)|prostate(1)|skin(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(2)	60	all_cancers(46;0.0316)|all_epithelial(25;0.00147)|Breast(12;0.0015)|Prostate(51;0.0146)		Epithelial(14;0.00105)|OV - Ovarian serous cystadenocarcinoma(4;0.00151)|all cancers(16;0.00446)			CAGAGGCCCCGCCCTCTTGGA	0.592		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													37	48	44	NA		NA	NA	10		NA											NA				79581222		2083	4112	6195	SO:0001583	missense			ENSG00000151208	HGNC:2904		Approved	uc001jzk.3	NA	A6H8Y3|Q149N1|Q5T1H7|Q5T1H8|Q6DKG3|Q86WC0|Q8TDM7|Q9UE73|Q9Y4E3	ENST00000372391.2	37	CCDS7353.2	.	.	.	.	.	.	.	.	.	.	G	5.801	0.332030	0.10956	.	.	ENSG00000151208	ENST00000372391;ENST00000372392	T	0.04119	3.7	5.87	-1.85	0.07784	.	0.969624	0.08390	N	0.953021	T	0.04137	0.0115	L	0.44542	1.39	0.24179	N	0.995594	B;B	0.06786	0.001;0.0	B;B	0.04013	0.001;0.0	T	0.48328	-0.9045	10	0.15499	T	0.54	.	6.0329	0.19690	0.2783:0.0:0.4441:0.2776	.	897;1007	Q8TDM6-4;Q8TDM6	.;DLG5_HUMAN	V	1007;556	ENSP00000361467:A1007V	ENSP00000361467:A1007V	A	-	2	0	DLG5	79251228	0.870000	0.30015	0.030000	0.17652	0.030000	0.12068	2.301000	0.43628	-0.156000	0.11079	-0.345000	0.07892	GCG	DLG5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000048900.2	81.704522	KEEP		-	88.097963	0.267176	35	96	---	---	---	---	1	1	47	56	0	106	38	113	0	106	2	0	0	0	0	0	0	38	113	0	106	2	TP
PFKM	5213	broad.mit.edu	37	12	48529142	48529142	+	Silent	SNP	G	G	A			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr12:48529142G>A	ENST00000340802.6	+	12	1349	c.1125G>A	c.(1123-1125)acG>acA	p.T375T	PFKM_ENST00000359794.5_Silent_p.T304T|PFKM_ENST00000312352.7_Silent_p.T304T|PFKM_ENST00000395233.2_Intron|PFKM_ENST00000547587.1_Silent_p.T304T|PFKM_ENST00000551804.1_Intron	NM_001166686.1	NP_001160158.1	P08237	K6PF_HUMAN	phosphofructokinase, muscle	304		NA		NA	fructose 6-phosphate metabolic process|glycolysis|muscle cell homeostasis	6-phosphofructokinase complex|apical plasma membrane	6-phosphofructokinase activity|ATP binding|identical protein binding|kinase binding|metal ion binding|protein C-terminus binding		NA	NS(3)|central_nervous_system(1)|cervix(1)|endometrium(2)|kidney(2)|large_intestine(4)|lung(16)|ovary(2)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	35						GGGGTGGGACGCCATCAGCCT	0.572		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													126	104	111	NA		NA	NA	12		NA											NA				48529142		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:8877	NM_000289	Approved	uc001rrb.2	NA	Q16814|Q16815	ENST00000340802.6	37	CCDS53786.1																																																																																			PFKM-001	PUTATIVE	downstream_ATG|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000406484.1	77.876736	KEEP		+	79.413111	0.353659	29	53	---	---	---	---	1	1	160	278	0	67	32	60	0	67	2	0	0	0	0	0	0	32	60	0	67	2	TP
ITGA7	3679	broad.mit.edu	37	12	56087909	56087909	+	Splice_Site	SNP	T	T	C			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr12:56087909T>C	ENST00000257880.7	-	20	2784		c.e20-2		ITGA7_ENST00000394230.2_Splice_Site|ITGA7_ENST00000452168.2_Splice_Site|ITGA7_ENST00000347027.6_Splice_Site|ITGA7_ENST00000257879.6_Splice_Site|ITGA7_ENST00000553804.1_Splice_Site|ITGA7_ENST00000394229.2_Splice_Site|ITGA7_ENST00000555728.1_Splice_Site			Q13683	ITA7_HUMAN	integrin, alpha 7	NA		NA		NA	cell-matrix adhesion|integrin-mediated signaling pathway|muscle organ development|regulation of cell shape	integrin complex	receptor activity		NA	breast(2)|central_nervous_system(1)|cervix(1)|endometrium(6)|kidney(1)|large_intestine(10)|lung(16)|ovary(2)|prostate(2)|skin(5)|soft_tissue(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	50						ATGGCCATTCTGGCGTGGAGA	0.592		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													104	77	86	NA		NA	NA	12		NA											NA				56087909		2203	4300	6503	SO:0001630	splice_region_variant				HGNC:6143	NM_002206	Approved	uc001shh.3	NA	B4E3U0|C9JMD3|C9JMZ6|O43197|Q9NY89|Q9UET0|Q9UEV2	ENST00000257880.7	37		.	.	.	.	.	.	.	.	.	.	T	11.72	1.723887	0.30593	.	.	ENSG00000135424	ENST00000553804;ENST00000257879;ENST00000347027;ENST00000452168;ENST00000257880;ENST00000394230;ENST00000394229;ENST00000353687;ENST00000555728	.	.	.	5.37	5.37	0.77165	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.627	0.62170	0.0:0.0:0.0:1.0	.	.	.	.	.	-1	.	.	.	-	.	.	ITGA7	54374176	0.885000	0.30320	0.998000	0.56505	0.080000	0.17528	1.990000	0.40717	2.156000	0.67533	0.482000	0.46254	.	ITGA7-201	KNOWN	basic	protein_coding	NA	protein_coding		11.588443	KEEP	Intron	-	18.559341	0.132075	7	46	---	---	---	---	1	0.9999993	337	23	0	32	7	49	0	32	2	0	0	0	0	0	0	7	49	0	32	2	TP
MTERFD3	80298	broad.mit.edu	37	12	107372183	107372183	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr12:107372183C>T	ENST00000552029.1	-	2	2378	c.310G>A	c.(310-312)Gca>Aca	p.A104T	MTERFD3_ENST00000392830.2_Missense_Mutation_p.A104T|MTERFD3_ENST00000240050.4_Missense_Mutation_p.A104T|C12orf23_ENST00000551237.1_3'UTR			Q49AM1	MTER3_HUMAN	MTERF domain containing 3	104		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	mitochondrial nucleoid	transcription regulatory region DNA binding		NA	breast(1)|kidney(1)|large_intestine(2)|lung(3)	7						CAGACAATTGCTTCCGGGCAG	0.423		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													136	146	143	NA		NA	NA	12		NA											NA				107372183		2203	4300	6503	SO:0001583	missense				HGNC:30779	NM_025198	Approved	uc001tmg.2	NA	Q53HM2|Q9H4L6|Q9H7Y9	ENST00000552029.1	37	CCDS9111.1	.	.	.	.	.	.	.	.	.	.	C	19.75	3.885976	0.72410	.	.	ENSG00000120832	ENST00000392830;ENST00000240050;ENST00000552029;ENST00000548101	T;T;T;T	0.12255	2.7;2.7;2.7;2.71	5.82	4.01	0.46588	.	0.049069	0.85682	N	0.000000	T	0.33673	0.0871	M	0.72894	2.215	0.58432	D	0.999999	D	0.89917	1.0	D	0.97110	1.0	T	0.02437	-1.1159	10	0.31617	T	0.26	-12.3428	12.3753	0.55277	0.0:0.8637:0.0:0.1363	.	104	Q49AM1	MTER3_HUMAN	T	104	ENSP00000376575:A104T;ENSP00000240050:A104T;ENSP00000447651:A104T;ENSP00000448343:A104T	ENSP00000240050:A104T	A	-	1	0	MTERFD3	105896313	1.000000	0.71417	0.941000	0.38009	0.557000	0.35523	4.692000	0.61746	0.808000	0.34231	-0.262000	0.10625	GCA	MTERFD3-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000406835.1	16.79965	KEEP		-	29.416381	0.134021	13	84	---	---	---	---	1	0.9995149	28	82	0	285	13	102	0	285	2	0	0	0	0	0	0	13	102	0	285	2	TP
EIF2B1	1967	broad.mit.edu	37	12	124116941	124116941	+	Silent	SNP	T	T	C			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr12:124116941T>C	ENST00000424014.2	-	2	274	c.66A>G	c.(64-66)tcA>tcG	p.S22S	GTF2H3_ENST00000543341.2_5'Flank|EIF2B1_ENST00000539951.1_Silent_p.S9S|EIF2B1_ENST00000543940.1_5'UTR|GTF2H3_ENST00000228955.7_5'Flank|EIF2B1_ENST00000537073.1_Silent_p.S22S	NM_001414.3	NP_001405.1	Q14232	EI2BA_HUMAN	eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa	22		NA		NA	cellular response to stimulus|oligodendrocyte development|regulation of translational initiation|response to glucose stimulus|response to heat|response to peptide hormone stimulus	cytosol|eukaryotic translation initiation factor 2B complex|membrane fraction|plasma membrane	protein binding|translation initiation factor activity		NA	breast(1)|kidney(3)|large_intestine(2)|lung(3)|urinary_tract(1)	10	all_neural(191;0.101)|Medulloblastoma(191;0.163)			OV - Ovarian serous cystadenocarcinoma(86;6.67e-05)|Epithelial(86;0.000353)|all cancers(50;0.00489)		CAGCCACTGCTGAGGCCATGT	0.398		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													111	126	121	NA		NA	NA	12		NA											NA				124116941		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000111361	HGNC:3257	NM_001414	Approved	uc001ufm.3	NA	A6NLY9|Q3SXP4	ENST00000424014.2	37	CCDS31924.1	.	.	.	.	.	.	.	.	.	.	T	11.40	1.628923	0.28978	.	.	ENSG00000111361	ENST00000534960	.	.	.	5.38	-2.33	0.06724	.	.	.	.	.	T	0.50240	0.1604	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.44436	-0.9328	4	.	.	.	-9.6253	6.3727	0.21491	0.1798:0.4019:0.0:0.4183	.	.	.	.	R	38	.	.	Q	-	2	0	EIF2B1	122682894	0.008000	0.16893	0.992000	0.48379	0.998000	0.95712	-1.324000	0.02690	-0.226000	0.09899	0.455000	0.32223	CAG	EIF2B1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400628.1	-23.484595	KEEP		-	17.714189	0.047619	9	180	---	---	---	---	1	0.9872363	2	130	0	238	13	231	0	238	2	0	0	0	0	0	0	13	231	0	238	2	TP
CHD8	57680	broad.mit.edu	37	14	21870120	21870120	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr14:21870120G>C	ENST00000399982.2	-	19	4122	c.4058C>G	c.(4057-4059)gCt>gGt	p.A1353G	CHD8_ENST00000430710.3_Missense_Mutation_p.A1074G|CHD8_ENST00000557364.1_Missense_Mutation_p.A1353G|CHD8_ENST00000555962.1_5'UTR	NM_001170629.1	NP_001164100.1	Q9HCK8	CHD8_HUMAN	chromodomain helicase DNA binding protein 8	1353		NA		NA	ATP-dependent chromatin remodeling|canonical Wnt receptor signaling pathway|negative regulation of transcription, DNA-dependent|negative regulation of Wnt receptor signaling pathway|positive regulation of transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase III promoter|transcription, DNA-dependent	MLL1 complex	ATP binding|beta-catenin binding|DNA binding|DNA helicase activity|DNA-dependent ATPase activity|methylated histone residue binding|p53 binding		NA	NS(2)|breast(1)|central_nervous_system(1)|cervix(4)|endometrium(8)|haematopoietic_and_lymphoid_tissue(2)|kidney(6)|large_intestine(8)|lung(33)|ovary(6)|prostate(7)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(2)	85	all_cancers(95;0.00121)		Epithelial(56;2.55e-06)|all cancers(55;1.73e-05)	GBM - Glioblastoma multiforme(265;0.00424)		ACATGCCTTAGCAAAGGTGGA	0.428		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													147	139	142	NA		NA	NA	14		NA											NA				21870120		1965	4182	6147	SO:0001583	missense				HGNC:20153	NM_020920	Approved	uc001war.2	NA	Q4G0D8|Q68DQ0|Q6DKH9|Q6P440|Q6ZNL7|Q8N3Z9|Q8NCY4|Q8TBR9|Q96F26	ENST00000399982.2	37	CCDS53885.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	26.8|26.8	4.773970|4.773970	0.90108|0.90108	.|.	.|.	ENSG00000100888|ENSG00000100888	ENST00000430710;ENST00000399982;ENST00000262707;ENST00000557364|ENST00000555935	D;D;D|.	0.86865|.	-2.18;-2.18;-2.18|.	6.17|6.17	6.17|6.17	0.99709|0.99709	.|.	0.057934|.	0.64402|.	D|.	0.000002|.	D|D	0.82733|0.82733	0.5101|0.5101	M|M	0.82517|0.82517	2.595|2.595	0.58432|0.58432	D|D	0.999999|0.999999	P;D|.	0.54047|.	0.939;0.964|.	P;P|.	0.56751|.	0.643;0.805|.	T|T	0.82121|0.82121	-0.0614|-0.0614	10|5	0.59425|.	D|.	0.04|.	-4.767|-4.767	19.6509|19.6509	0.95805|0.95805	0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0	.|.	1353;1074|.	Q9HCK8;Q9HCK8-2|.	CHD8_HUMAN;.|.	G|W	1074;1353;1073;1353|578	ENSP00000406288:A1074G;ENSP00000382863:A1353G;ENSP00000451601:A1353G|.	ENSP00000262707:A1073G|.	A|C	-|-	2|3	0|2	CHD8|CHD8	20939960|20939960	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.989000|0.989000	0.77384|0.77384	9.813000|9.813000	0.99286|0.99286	2.941000|2.941000	0.99782|0.99782	0.655000|0.655000	0.94253|0.94253	GCT|TGC	CHD8-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		58.978059	KEEP		-	75.00085	0.165563	25	126	---	---	---	---	1	0.9991097	2	62	0	183	27	149	0	183	2	0	0	0	0	0	0	27	149	0	183	2	TP
TP53	7157	broad.mit.edu	37	17	7577121	7577121	+	Missense_Mutation	SNP	G	G	A	rs121913343		GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr17:7577121G>A	ENST00000420246.2	-	8	949	c.817C>T	c.(817-819)Cgt>Tgt	p.R273C	TP53_ENST00000413465.2_Intron|TP53_ENST00000359597.4_Missense_Mutation_p.R273C|TP53_ENST00000445888.2_Missense_Mutation_p.R273C|TP53_ENST00000269305.4_Missense_Mutation_p.R273C|TP53_ENST00000574684.1_5'Flank|TP53_ENST00000455263.2_Missense_Mutation_p.R273C	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	273	Interaction with AXIN1 (By similarity).|Interaction with DNA.|Interaction with E4F1.|Interaction with HIPK1 (By similarity).	NA	R -> C (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> G (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> H (in LFS; germline mutation and in sporadic cancers; somatic mutation; abolishes sequence-specific DNA binding; dbSNP:rs28934576).|R -> L (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> N (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|R -> P (in sporadic cancers; somatic mutation).|R -> Q (in sporadic cancers; somatic mutation).|R -> S (in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> Y (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.R273C(481)|p.R273S(16)|p.R273G(9)|p.0?(8)|p.?(2)|p.R273fs*72(2)|p.R273fs*33(2)|p.R273fs*32(2)|p.V272>?(2)|p.F270fs*72(1)|p.R273_C275delRVC(1)|p.L265_K305del41(1)|p.S269fs*21(1)|p.E258fs*71(1)|p.R273fs*71(1)|p.F270_D281del12(1)|p.E271_R273delEVR(1)|p.V272_K292del21(1)	NA	NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GCACAAACACGCACCTCAAAG	0.542	R273C(8MGBA_CENTRAL_NERVOUS_SYSTEM)|R273C(BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(EFO27_OVARY)|R273C(KARPAS299_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(MFE319_ENDOMETRIUM)|R273C(NCIH1048_LUNG)|R273C(PANC0213_PANCREAS)|R273C(PF382_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(RDES_BONE)|R273C(RH30_SOFT_TISSUE)|R273C(RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(SH10TC_STOMACH)|R273C(SJRH30_SOFT_TISSUE)|R273C(SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(SW1710_URINARY_TRACT)|R273C(SW1783_CENTRAL_NERVOUS_SYSTEM)|R273C(TT2609C02_THYROID)	111	"""Mis, N, F"""	NA	"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	533	Substitution - Missense(506)|Whole gene deletion(8)|Deletion - Frameshift(8)|Deletion - In frame(5)|Insertion - Frameshift(2)|Unknown(2)|Complex(2)	central_nervous_system(117)|large_intestine(108)|ovary(32)|haematopoietic_and_lymphoid_tissue(31)|upper_aerodigestive_tract(30)|stomach(25)|urinary_tract(23)|lung(21)|breast(21)|liver(20)|endometrium(17)|oesophagus(17)|bone(16)|pancreas(15)|prostate(8)|skin(7)|cervix(6)|biliary_tract(6)|kidney(3)|thyroid(3)|vulva(2)|genital_tract(1)|penis(1)|adrenal_gland(1)|salivary_gland(1)|small_intestine(1)	GRCh37	CM010471|CM010473|CM951233	TP53	M	rs121913343						65	56	59	NA		NA	NA	17		NA											NA				7577121		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	G	17.48	3.400216	0.62177	.	.	ENSG00000141510	ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000509690	D;D;D;D;D;D	0.99869	-7.34;-7.34;-7.34;-7.34;-7.34;-7.34	4.92	3.95	0.45737	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99851	0.9931	M	0.90759	3.145	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.91635	0.998;0.998;0.999;0.996	D	0.96877	0.9643	10	0.87932	D	0	-11.9995	11.2235	0.48869	0.0895:0.0:0.9105:0.0	.	273;273;273;273	P04637-2;P04637-3;P04637;Q1MSW8	.;.;P53_HUMAN;.	C	273;273;273;273;273;262;141	ENSP00000352610:R273C;ENSP00000269305:R273C;ENSP00000398846:R273C;ENSP00000391127:R273C;ENSP00000391478:R273C;ENSP00000425104:R141C	ENSP00000269305:R273C	R	-	1	0	TP53	7517846	1.000000	0.71417	0.066000	0.19879	0.723000	0.41478	4.540000	0.60664	1.299000	0.44798	0.462000	0.41574	CGT	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	48.729597	KEEP		-	48.943245	0.592593	16	11	---	---	---	---	1	1	55	17	0	30	17	12	0	30	2	1	1	358	216	0	847	17	12	0	30	2	TP
BPTF	2186	broad.mit.edu	37	17	65862640	65862640	+	Silent	SNP	A	A	G			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr17:65862640A>G	ENST00000321892.4	+	3	1558	c.1497A>G	c.(1495-1497)caA>caG	p.Q499Q	BPTF_ENST00000306378.6_Silent_p.Q499Q|BPTF_ENST00000335221.5_Silent_p.Q499Q|BPTF_ENST00000424123.3_Silent_p.Q360Q			Q12830	BPTF_HUMAN	bromodomain PHD finger transcription factor	499		NA		NA	brain development|chromatin remodeling|negative regulation of transcription from RNA polymerase II promoter|positive regulation of transcription, DNA-dependent|transcription, DNA-dependent	cytoplasm|NURF complex	sequence-specific DNA binding|transcription factor binding|zinc ion binding		NA	NS(1)|breast(1)|central_nervous_system(3)|cervix(1)|endometrium(11)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(16)|lung(23)|ovary(3)|pancreas(2)|prostate(4)|skin(4)|upper_aerodigestive_tract(1)|urinary_tract(2)	78	all_cancers(12;6e-11)		BRCA - Breast invasive adenocarcinoma(8;7.48e-08)|Colorectal(3;0.0984)|LUSC - Lung squamous cell carcinoma(166;0.24)			CAAAGGTCCAACTTGCAGAAT	0.343		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													85	96	92	NA		NA	NA	17		NA											NA				65862640		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000171634	HGNC:3581	NM_182641, NM_004459	Approved	uc002jgf.3	NA	Q6NX67|Q7Z7D6|Q9UIG2	ENST00000321892.4	37																																																																																				BPTF-201	KNOWN	basic	protein_coding	NA	protein_coding		-8.129821	KEEP		+	6.436049	0.045455	3	63	---	---	---	---	1	0.203694	5	10	0	175	3	68	0	175	2	0	0	0	0	0	0	3	68	0	175	2	TP
SLC14A2	8170	broad.mit.edu	37	18	43224152	43224152	+	Intron	SNP	C	C	T			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr18:43224152C>T	ENST00000255226.6	+	10	2167				RP11-116O18.1_ENST00000590535.1_RNA|SLC14A2_ENST00000586448.1_Intron	NM_007163.3	NP_009094.3	Q15849	UT2_HUMAN	solute carrier family 14 (urea transporter), member 2	NA		NA		NA		apical plasma membrane|integral to membrane|membrane fraction	protein binding|urea transmembrane transporter activity		NA	NS(1)|central_nervous_system(1)|endometrium(5)|kidney(4)|large_intestine(8)|lung(35)|ovary(1)|prostate(1)|skin(3)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	63						GGGGAAGAAACGCTCTTTGCC	0.537		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													73	72	72	NA		NA	NA	18		NA											NA				43224152		2203	4300	6503	SO:0001627	intron_variant			ENSG00000132874	HGNC:10919		Approved	uc010dnj.3	NA	A8K8Q7|Q2TBD6|Q96PH5	ENST00000255226.6	37	CCDS11924.1																																																																																			SLC14A2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255858.1	54.913221	KEEP		+	55.956545	0.351852	19	35	---	---	---	---	1	0.9706745	4	10	0	56	19	35	0	56	2	0	0	0	0	0	0	19	35	0	56	2	TP
SOCS6	9306	broad.mit.edu	37	18	67992496	67992496	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr18:67992496A>G	ENST00000397942.3	+	2	908	c.592A>G	c.(592-594)Aat>Gat	p.N198D	SOCS6_ENST00000582322.1_Missense_Mutation_p.N198D	NM_004232.3	NP_004223.2	O14544	SOCS6_HUMAN	suppressor of cytokine signaling 6	198		NA		NA	defense response|JAK-STAT cascade|negative regulation of signal transduction|regulation of growth	cytoplasm			NA	NS(1)|breast(2)|endometrium(1)|kidney(2)|large_intestine(4)|lung(9)|ovary(1)|prostate(2)	22		Esophageal squamous(42;0.129)|Colorectal(73;0.152)				GGCTTCTCATAATGGAGACCT	0.512		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(84;1024 1361 24382 36583 42651)							NA		NA		0													108	94	99	NA		NA	NA	18		NA											NA				67992496		2203	4300	6503	SO:0001583	missense			ENSG00000170677	HGNC:16833		Approved	uc002lkr.1	NA	Q8WUM3	ENST00000397942.3	37	CCDS11998.1	.	.	.	.	.	.	.	.	.	.	A	11.37	1.619214	0.28801	.	.	ENSG00000170677	ENST00000397942	T	0.25085	1.82	5.12	0.264	0.15607	.	0.487639	0.20210	N	0.096926	T	0.19967	0.0480	L	0.46157	1.445	0.09310	N	1	B	0.06786	0.001	B	0.04013	0.001	T	0.18335	-1.0340	10	0.51188	T	0.08	-2.7492	8.3611	0.32359	0.6733:0.0:0.3267:0.0	.	198	O14544	SOCS6_HUMAN	D	198	ENSP00000381034:N198D	ENSP00000381034:N198D	N	+	1	0	SOCS6	66143476	0.075000	0.21258	0.000000	0.03702	0.102000	0.19082	1.557000	0.36299	0.023000	0.15187	0.459000	0.35465	AAT	SOCS6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256270.2	21.57038	KEEP		+	32.928906	0.129412	11	74	---	---	---	---	1	0.9942951	6	49	0	105	13	76	0	105	2	0	0	0	0	0	0	13	76	0	105	2	TP
LMNB2	84823	broad.mit.edu	37	19	2444529	2444529	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr19:2444529T>C	ENST00000325327.3	-	2	336	c.274A>G	c.(274-276)Atc>Gtc	p.I92V	LMNB2_ENST00000582871.1_Missense_Mutation_p.I72V			Q03252	LMNB2_HUMAN	lamin B2	72	Coil 1B.|Rod.	NA		NA		nuclear inner membrane	structural molecule activity		NA	NS(1)|endometrium(1)|kidney(1)|large_intestine(3)|lung(8)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	18		Hepatocellular(1079;0.137)		UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|OV - Ovarian serous cystadenocarcinoma(105;1.09e-113)|Epithelial(107;3.79e-112)|all cancers(105;1.67e-104)|BRCA - Breast invasive adenocarcinoma(158;0.00136)|STAD - Stomach adenocarcinoma(1328;0.18)		AGCGCCTTGATGCCACTCACC	0.642		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													81	68	72	NA		NA	NA	19		NA											NA				2444529		2203	4300	6503	SO:0001583	missense			ENSG00000176619	HGNC:6638	NM_032737	Approved	uc002lvy.4	NA	O75292|Q14734|Q96DF6	ENST00000325327.3	37	CCDS12090.2	.	.	.	.	.	.	.	.	.	.	T	14.14	2.447176	0.43429	.	.	ENSG00000176619	ENST00000325327	.	.	.	4.04	4.04	0.47022	Filament (1);	0.135395	0.49305	D	0.000149	T	0.53981	0.1830	L	0.39898	1.24	0.51482	D	0.999923	B	0.20052	0.041	B	0.31101	0.124	T	0.50145	-0.8862	9	0.29301	T	0.29	.	11.8181	0.52222	0.0:0.0:0.0:1.0	.	72	Q03252	LMNB2_HUMAN	V	72	.	ENSP00000327054:I72V	I	-	1	0	LMNB2	2395529	1.000000	0.71417	1.000000	0.80357	0.977000	0.68977	1.583000	0.36579	1.481000	0.48307	0.459000	0.35465	ATC	LMNB2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000319205.3	25.915501	KEEP		-	30.707188	0.196429	11	45	---	---	---	---	1	0.7887063	9	18	1	52	12	49	1	52	4	0	0	0	0	0	0	12	49	1	52	2	TP
PGLS	25796	broad.mit.edu	37	19	17626983	17626983	+	Splice_Site	SNP	C	C	T	rs143569199		GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr19:17626983C>T	ENST00000252603.2	+	2	334	c.288_splice	c.e2-1	p.T97_splice	CTD-3131K8.3_ENST00000596192.1_RNA	NM_012088.2	NP_036220.1	O95336	6PGL_HUMAN	6-phosphogluconolactonase	97		NA		NA		cytosol	6-phosphogluconolactonase activity		NA	endometrium(1)|lung(1)	2						TGGCTGCAGACGCATCTTCTC	0.537		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0								C	MET/THR	0,4406		0,0,2203	110	78	89	NA	290	3.8	1	19	dbSNP_134	89	1,8599	1.2+/-3.3	0,1,4299	no	missense-near-splice	PGLS	NM_012088.2	81	0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077	probably-damaging	97/259	17626983	1,13005	2203	4300	6503	SO:0001630	splice_region_variant				HGNC:8903		Approved	uc002ngw.3	NA		ENST00000252603.2	37	CCDS12361.1	.	.	.	.	.	.	.	.	.	.	C	11.20	1.569663	0.28003	0.0	1.16E-4	ENSG00000130313	ENST00000252603	T	0.44083	0.93	4.84	3.8	0.43715	Glucosamine/galactosamine-6-phosphate isomerase (1);6-phosphogluconolactonase, DevB-type (1);	0.293340	0.37761	N	0.001943	T	0.56819	0.2011	M	0.69358	2.11	0.31298	N	0.68861	D	0.71674	0.998	D	0.65773	0.938	T	0.62581	-0.6824	10	0.56958	D	0.05	-39.1078	9.3426	0.38089	0.0:0.8989:0.0:0.1011	.	97	O95336	6PGL_HUMAN	M	97	ENSP00000252603:T97M	ENSP00000252603:T97M	T	+	2	0	PGLS	17487983	1.000000	0.71417	0.999000	0.59377	0.016000	0.09150	2.301000	0.43628	1.026000	0.39733	-0.224000	0.12420	ACG	PGLS-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000464154.1	51.941114	KEEP	Missense_Mutation	+	52.190037	0.418605	18	25	---	---	---	---	1	1	69	122	0	40	19	29	0	40	2	0	0	0	0	0	0	19	29	0	40	2	TP
ACOT8	10005	broad.mit.edu	37	20	44477248	44477248	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-1442-Tumor-SM-1Y48B	GBM-TCGA-26-1442-Normal-SM-1Y486	g.chr20:44477248C>T	ENST00000217455.4	-	3	419	c.329G>A	c.(328-330)cGc>cAc	p.R110H		NM_005469.3	NP_005460.2	O14734	ACOT8_HUMAN	acyl-CoA thioesterase 8	110		NA		NA	bile acid biosynthetic process|fatty acid beta-oxidation using acyl-CoA oxidase|interspecies interaction between organisms|peroxisome organization	peroxisomal matrix	acetyl-CoA hydrolase activity|acyl-CoA thioesterase activity|carboxylesterase activity|choloyl-CoA hydrolase activity|protein binding		NA	kidney(2)|large_intestine(3)|lung(4)|skin(1)	10		Myeloproliferative disorder(115;0.0122)				CTTCACAGAGCGCACCGAGAA	0.627		NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													134	119	124	NA		NA	NA	20		NA											NA				44477248		2203	4300	6503	SO:0001583	missense			ENSG00000101473	HGNC:15919	NM_183386	Approved	uc002xqa.2	NA	O15261|Q17RX4	ENST00000217455.4	37	CCDS13378.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	19.13|19.13	3.767685|3.767685	0.69878|0.69878	.|.	.|.	ENSG00000101473|ENSG00000101473	ENST00000487205|ENST00000217455	.|.	.|.	.|.	5.38|5.38	5.38|5.38	0.77491|0.77491	.|.	.|0.000000	.|0.85682	.|D	.|0.000000	D|D	0.91280|0.91280	0.7251|0.7251	H|H	0.98901|0.98901	4.365|4.365	0.80722|0.80722	D|D	1|1	.|D;D;D	.|0.89917	.|1.0;1.0;1.0	.|D;D;D	.|0.97110	.|1.0;1.0;1.0	D|D	0.94377|0.94377	0.7601|0.7601	6|9	0.72032|0.87932	D|D	0.01|0	.|.	19.3333|19.3333	0.94303|0.94303	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	.|110;57;110	.|B4DLF4;A8K8X9;O14734	.|.;.;ACOT8_HUMAN	T|H	65|110	.|.	ENSP00000433923:A131T|ENSP00000217455:R110H	A|R	-|-	1|2	0|0	ACOT8|ACOT8	43910655|43910655	1.000000|1.000000	0.71417|0.71417	0.989000|0.989000	0.46669|0.46669	0.985000|0.985000	0.73830|0.73830	7.126000|7.126000	0.77201|0.77201	2.793000|2.793000	0.96121|0.96121	0.655000|0.655000	0.94253|0.94253	GCT|CGC	ACOT8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000080338.2	36.848547	KEEP		-	51.811107	0.160584	22	115	---	---	---	---	1	1	31	202	0	110	26	121	0	110	2	0	0	0	0	0	0	26	121	0	110	2	TP
